Kilitch Drugs (India) informs about disclosure

21 Jun 2019 Evaluate

Kilitch Drugs (India) has informed that the Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavin Mehta.

The above information is a part of company’s filings submitted to BSE.

Kilitch Drugs(India) Share Price

345.05 -6.25 (-1.78%)
08-Jan-2025 09:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1869.75
Dr. Reddys Lab 1370.90
Cipla 1498.60
Lupin 2352.55
Zydus Lifesciences 1010.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.